Old Articles: <Older 8381-8390 Newer> |
|
Chemistry World August 9, 2012 |
Bapineuzunab dropped Pfizer and Johnson and Johnson have announced that they are ending development of the intravenous Alzheimer's drug bapineuzumab after it failed in two clinical trials. |
Chemistry World August 7, 2012 Anthony King |
Irish pharma exports tumble Irish pharma exports to the US declined 30% in the first six months of this year as a clatter of blockbuster drugs made in Ireland, such as Lipitor (atorvastatin), came off patent. |
Chemistry World August 3, 2012 Andrew Turley |
Pfizer secures Sandwich buyer Pfizer has found a buyer for its R&D site in Sandwich, UK: the site -- now called Discovery Park -- has been bought by a private consortium, according to Kent County Council. |
Chemistry World August 2, 2012 |
Monsanto wins $1bn in patent case A US court has awarded $1 billion in damages to Monsanto following a patent dispute with DuPont over crops bred to be resistant to the popular pesticide glyphosphate. |
Chemistry World July 31, 2012 Andrew Turley |
New cystic fibrosis drug in EU Ivacaftor, which is marketed under the brand name Kalydeco, won US approval in January. |
Chemistry World July 25, 2012 |
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. |
Chemistry World July 20, 2012 Andrew Turley |
GSK secures $3.6bn HGS deal After months of wrangling, GlaxoSmithKline has found enough common ground with Human Genome Sciences for the two to sign up to a $3.6 billion takeover deal. |
Chemistry World July 18, 2012 Andrew Turley |
Obesity drug approved in US US regulators have approved a new obesity treatment. Qsymia (phentermine, topiramate) tablets have been approved for overweight adults as part of a regimen that includes a low calorie diet and exercise. |
Chemistry World July 17, 2012 Andrew Turley |
First HIV drug approved as prevention US regulators have for the first time approved a drug to be used to prevent HIV infection -- as opposed to treating it. |
Chemistry World July 16, 2012 Andrew Turley |
Drug spending to hit $1.2tn in 2016 Global expenditure on medicines will top $1.2 trillion in 2016, up from $960 billion in 2011, according to a report from the IMS Institute for Healthcare Informatics. |
<Older 8381-8390 Newer> Return to current articles. |